# Colchicine in Chronic Kidney Disease Patients

Study · id `cardio:ct-nct06998862` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06998862](<https://clinicaltrials.gov/study/NCT06998862>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06998862

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 744 participants.

## Technical summary

Registry record NCT06998862. Randomized; triple masking; primary purpose prevention. Start 2025-02-12 (actual); primary completion 2028-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 744 participants (planned count; ClinicalTrials.gov record NCT06998862, source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)
- Started: 2025-02-12 (actual) (ClinicalTrials.gov record NCT06998862, source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)
- Primary completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT06998862, source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)
- Completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT06998862, source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT06998862, source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06998862-2025-05-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine in Chronic Kidney Disease Patients
- Acronym: COLCHIREN
- Condition: Chronic Kidney Disease
- Condition: Cardiovascular Events
- Intervention (Drug): colchicine treatment in chronic kidney disease patients
- Intervention (Drug): placebo treatment
- Lead sponsor: Hospital General Universitario Gregorio Marañon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Hospital General Universitario Gregorio Marañon (`cardio:org-hospital-general-universitario-gregorio-maranon`)

## Provenance

Content hash: 04fba0c6df4a29e5e38ceb2207a529837b06be5d67be7ff21dfe2d095e8e8a89
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
